Filing search / Pulmatrix, Inc. / "Targets" / Page 5

8-K

EX-99.1

f811km9j

2 Jan 20

Pulmatrix Announces Kinase Inhibitor Licensing Agreement

9:45am

8-K

EX-99.1

sy2ie

4 Nov 19

Pulmatrix appoints Life Sciences Executive Rick Batycky to the Board of Directors

9:43am

8-K

EX-99.1

ceiltki5ttt

1 Nov 19

Pulmatrix Reports Q3 2019 Results

9:05am

8-K

EX-99.1

xclci3b3

22 Aug 19

Regulation FD Disclosure

9:00am

8-K

EX-99.1

uro 2fk10

5 Aug 19

Pulmatrix Reports Q2 2019 Results

9:05am

8-K

EX-99.1

8hcxaow2o k4sdj

16 May 19

Pulmatrix Announces Leadership Change

9:15am

8-K

EX-99.1

4tf11n5ms 3ps

15 May 19

Pulmatrix Reports Q1 2019 Results

9:06am

424B4

kggdm0xsz

5 Apr 19

Prospectus supplement with pricing info

4:31pm

8-K

EX-99.1

9aqvd6 7g

19 Feb 19

Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline

9:05am

8-K

EX-99.2

pxugmz1 84yns

11 Feb 19

Entry into a Material Definitive Agreement

5:18pm

424B5

m2gyy 17r7

11 Feb 19

Prospectus supplement for primary offering

5:13pm